<VariationArchive VariationID="3062120" VariationName="NM_015338.6(ASXL1):c.2456del (p.Gly819fs)" VariationType="Deletion" Accession="VCV003062120" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-23" DateCreated="2024-03-23" MostRecentSubmission="2024-03-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3222348" VariationID="3062120">
      <GeneList>
        <Gene Symbol="ASXL1" FullName="ASXL transcriptional regulator 1" GeneID="171023" HGNC_ID="HGNC:18318" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20q11.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="32358331" stop="32439319" display_start="32358331" display_stop="32439319" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="30946146" stop="31027121" display_start="30946146" display_stop="31027121" Strand="+" />
          </Location>
          <OMIM>612990</OMIM>
          <Haploinsufficiency last_evaluated="2013-03-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ASXL1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-03-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ASXL1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_015338.6(ASXL1):c.2456del (p.Gly819fs)</Name>
      <CanonicalSPDI>NC_000020.11:32435165:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>20q11.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="32435166" stop="32435166" display_start="32435166" display_stop="32435166" variantLength="1" positionVCF="32435165" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="31022969" stop="31022969" display_start="31022969" display_stop="31022969" variantLength="1" positionVCF="31022968" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>G758fs</ProteinChange>
      <ProteinChange>G819fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_630" sequenceAccession="LRG_630">
            <Expression>LRG_630:g.81825del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_630t1" sequenceAccession="LRG_630t1">
            <Expression>LRG_630t1:c.2456del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_630p1" sequenceAccession="LRG_630p1" change="p.Gly819Glufs">
            <Expression>LRG_630p1:p.Gly819Glufs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.31022971del" Assembly="GRCh37">
            <Expression>NC_000020.10:g.31022971del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.32435168del" Assembly="GRCh38">
            <Expression>NC_000020.11:g.32435168del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_027868.1" sequenceAccession="NG_027868" sequenceVersion="1" change="g.81825del">
            <Expression>NG_027868.1:g.81825del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363734.1" sequenceAccession="NM_001363734" sequenceVersion="1" change="c.2273del">
            <Expression>NM_001363734.1:c.2273del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350663.1" sequenceAccession="NP_001350663" sequenceVersion="1" change="p.Gly758fs">
            <Expression>NP_001350663.1:p.Gly758fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015338.6" sequenceAccession="NM_015338" sequenceVersion="6" change="c.2456del" MANESelect="true">
            <Expression>NM_015338.6:c.2456del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056153.2" sequenceAccession="NP_056153" sequenceVersion="2" change="p.Gly819fs">
            <Expression>NP_056153.2:p.Gly819fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015338.6(ASXL1):c.2456del (p.Gly819fs) AND Bohring-Opitz syndrome" Accession="RCV003985230" Version="1">
        <ClassifiedConditionList TraitSetID="1273">
          <ClassifiedCondition DB="MedGen" ID="C0796232">Bohring-Opitz syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-04-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-04-30" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-03-23" MostRecentSubmission="2024-03-23">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1273" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1074" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">C-like syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Opitz trigonocephaly-like syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Bohring-Opitz syndrome</ElementValue>
                <XRef ID="MONDO:0011510" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bohring syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BOS syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BOPS</ElementValue>
                <XRef Type="MIM" ID="605039" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Bohring-Opitz syndrome (BOS) is characterized by distinctive facial features and posture, growth failure, variable but usually severe intellectual disability, and variable anomalies. The facial features may include microcephaly or trigonocephaly / prominent (but not fused) metopic ridge, hypotonic facies with full cheeks, synophrys, glabellar and eyelid nevus flammeus (simplex), prominent globes, widely set eyes, palate anomalies, and micrognathia. The BOS posture, which is most striking in early childhood and often becomes less apparent with age, is characterized by flexion at the elbows with ulnar deviation and flexion of the wrists and metacarpophalangeal joints. Feeding difficulties in early childhood, including cyclic vomiting, have a significant impact on overall health; feeding tends to improve with age. Seizures are common and typically responsive to standard epileptic medications. Minor cardiac anomalies and transient bradycardia and apnea may be present. Affected individuals may experience recurrent infections, which also tend to improve with age. Isolated case reports suggest that individuals with BOS are at greater risk for Wilms tumor than the general population, but large-scale epidemiologic studies have not been conducted.</Attribute>
                <XRef ID="NBK481833" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10140" />
                <XRef ID="10140" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29446906</ID>
                <ID Source="BookShelf">NBK481833</ID>
              </Citation>
              <XRef ID="97297" DB="Orphanet" />
              <XRef ID="C0796232" DB="MedGen" />
              <XRef ID="MONDO:0011510" DB="MONDO" />
              <XRef Type="MIM" ID="605039" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8977701" SubmissionDate="2024-03-19" DateLastUpdated="2024-03-23" DateCreated="2024-03-23">
        <ClinVarSubmissionID localKey=":Chr.20_31022968_31022969_TG_T|OMIM:605039" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004801597" DateUpdated="2024-03-23" DateCreated="2024-03-23" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-04-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The ASXL1 c.2456delG p.(Gly819GlufsTer5) variant causes a shift in the protein reading frame that is predicted to result in premature termination of the protein. Loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay is expected. To our knowledge, this variant has not been reported in the peer-reviewed literature. This variant is not found in Genome Aggregation Database (version 2.1.1). The variant was identified in a de novo state in the proband. Based on the available evidence, the c.2456delG p.(Gly819GlufsTer5) variant is classified as pathogenic for Bohring-Optiz syndrome.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSLVariantClassificationCriteria RUGD 01 April 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/dy7elfgy/icslvariantclassificationcriteria_rugd_01_april_2020.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="20" alternateAllele="T" referenceAllele="TG" start="31022968" stop="31022969" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605039" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14324016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8977701" TraitType="Disease" MappingType="XRef" MappingValue="605039" MappingRef="OMIM">
        <MedGen CUI="C0796232" Name="Bohring-Opitz syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

